© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
March 04, 2016
With recent therapeutic advances, the treatment landscape for metastatic castration-resistant prostate cancer is changing rapidly.
March 02, 2016
Nanoparticles acting as cancer drug delivery vehicles show promise in eliminating tumors.
March 01, 2016
Controversy swirls around the naming protocol for biosimilars among drug manufacturers and the FDA.
February 29, 2016
Mergers and acquisitions among pharmacy benefit managers may help limit medication cost hikes.
February 26, 2016
Transition of provider-administered drugs from the physician office to the hospital remains a key cost driver of pharmacy spend.
There are several ongoing global phase 3 clinical trials for biosimilar adalimumab, which treats conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's Disease.